Advertisement

Topics

"Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib" Drugs and Medication Database

11:53 EST 18th December 2018 | BioPortfolio

Here are the most relevant "Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib" Drugs and Medications that we have found in our database.

More Information about "Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib" on BioPortfolio

We have published hundreds of Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib news stories on BioPortfolio along with dozens of Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib Clinical Trials and PubMed Articles about Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib Companies in our database. You can also find out about relevant Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib Drugs and Medications on this site too.

Showing "Trial Evaluate Improvement Chronic grade Patients With With" Drugs and Medications 1–25 of 406

Probably Relevant

Bite beauty spf 15 sheer balm [Susanne Lang Fragrance Inc.]

Bite Beauty SPF 15 Sheer Balm

Yervoy [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY (ipilimumab)Injection, for intravenous infusionInitial U.S. Approval: 2011

Metronidazole [Actavis Mid Atlantic LLC, Lincolnton, NC 28092]

Metronidazole Topical Lotion 0.75%

Gemcitabine hydrochloride [APP Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP.Gemcitabine for Injection, USP, Powder, Lyophilized, For Solution

Arzerra [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA.ARZERRA (ofatumumab)Injection, for intravenous infusionInitial U.S. Approval: 2009

Docetaxel [Winthrop U.S.]

These highlights do not include all the information needed to use docetaxel safely and effectively. See full prescribing information for docetaxel.  Docetaxel Injection Concentrate, Intravenous Infusion (IV). Initial U.S. Approval: 1996

Taxotere [sanofi-aventis U.S. LLC]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE (docetaxel) Injection Concentrate, Intravenous Infusion (IV). Initial U.S. Approval: 1996

Taxotere [sanofi-aventis U.S. LLC]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE.  TAXOTERE (docetaxel) Injection Concentrate, Intravenous Infusion (IV). Initial U.S. Approval: 1996

Docetaxel [Hospira, Inc.]

These highlights do not include all the information needed to use Docetaxel Injection safely and effectively. See full prescribing information for Docetaxel.Docetaxel Injection,For intravenous infusion only.Initial U.S. Approval: 1996

Arzerra [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. ARZERRA (ofatumumab)Injection, for intravenous infusionInitial U.S. Approval: 2009

Temodar [Schering Corporation]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) for Injection administered via intravenous infusion

Temodar [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) for Injection administered via intravenous infusion

Docetaxel [Accord Healthcare Inc.]

These highlights do not include all the information needed to use Docetaxel Injection safely and effectively. See full prescribing information for Docetaxel Injection. Docetaxel Injection, Intravenous Infusion. Initial U.S. Approval: 1996

Zelboraf [Genentech, Inc.]

These highlights do not include all the information needed to use ZELBORAF safely and effectively. See full prescribing information for ZELBORAF. ZELBORAF™ (vemurafenib) tablet, oralInitial U.S. Approval: 2011

Oxaliplatin [Teva Parenterals Medicines, Inc.]

These highlights do not include all the information needed to use Oxaliplatin Injection safely and effectively. See full prescribing information for Oxaliplatin Injection.  Oxaliplatin Injection (Oxaliplatin Injection) concentrate, for solution for intr

Oxaliplatin [APP Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Oxaliplatin for Injection safely and effectively. See full prescribing information for Oxaliplatin for Injection. OXALIPLATIN FOR INJECTION powder, for solution for intravenous useIni

Docetaxel [Sandoz Inc]

These highlights do not include all the information needed to use Docetaxel Injection safely and effectively. See full prescribing information for Docetaxel Injection.Docetaxel Injection, Solution for Intravenous Infusion Initial U.S. Approval: 1996

Possibly Relevant

Oxaliplatin [Hospira Worldwide, Inc.]

These highlights do not include all the information needed to use Oxaliplatin Injection safely and effectively. See full prescribing information for Oxaliplatin Injection. Oxaliplatin for Injection, powder for solution for intravenous use Oxaliplatin Inje

Xalkori [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use XALKORI safely and effectively. See full prescribing information for XALKORI. XALKORI (crizotinib) Capsules, oral Initial U.S. Approval: August 2011

Oxaliplatin [APP Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Oxaliplatin Injection safely and effectively. See full prescribing information for Oxaliplatin Injection.Oxaliplatin Injection concentrate, for solution for intavenous use Initial U.S. App

Treanda [Cephalon, Inc.]

These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA (bendamustine hydrochloride) injection, powder, lyophilized, for solution for intravenous use

Avastin [Genentech, Inc.]

These highlights do not include all the information needed to use AVASTIN safely and effectively. See full prescribing information for AVASTIN. AVASTIN (bevacizumab) Solution for intravenous infusion Initial U.S. Approval: 2004

Alimta [Eli Lilly and Company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection) Lyophilized Powder, for Solution for Intravenous Use Initial U.S. Approval: 2

Nexavar [Bayer HealthCare Pharmaceuticals Inc.]

These highlights do not include all the information needed to use NEXAVAR safely and effectively. See full prescribing information for NEXAVAR.Initial U.S. Approval: 2005

Xeloda [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use XELODA® safely and effectively. See full prescribing information for XELODA®. XELODA® (capecitabine) Tablets, Film Coated for Oral use Initial U.S. Approval: 1998



Advertisement
Quick Search
Advertisement
Advertisement